Sponsored SymposiaStructural heart disease

SOLACI-CACI 2021 | Current Controversies in Post-TAVR CORONARY ACCESS – Medtronic Symposium

solaci
solaci
599
0

✔️ MEDTRONIC Symposium in the SOLACI-CACI 2021 Virtual Congress.
✔️ Topic: Current Controversies in Post-TAVR CORONARY ACCESS.

👨‍🏫 Program:

  • 00:07 – Opening – Fabrio Brito.
  • 03:03 – Resolving Coronary Access after TAVR Implantation – Oscar Millan.
  • 18:20 – Deferred Access. Acute Coronary Syndrome I in a TAVR Patient – Henrique Ribeiro.
  • 39:44 – Acute Coronary Syndrome II in a TAVR Patient – Matías Sztejfman.
  • 51:41 – Discussion: The Role of Commissural Alignment Selecting a Guidewire Tips & Tricks.
  • 57:43 – Final Comments and Closing – Fabio Brito.

👉 Moderator: Dr. Fabio Brito.
👉 Panelists: Dr. Carla Agatiello – Dr. Fabio Brito- Dr. Pablo Charry – Dr. Luis Gutiérrez – Dr. Oscar Millán – Dr. Henrique Ribeiro – Dr. Matías Sztejfman.

This event took place on August 5th, 2021.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-CACI 2021 | Current CONTROVERSIES in INTERVENTIONAL CARDIOLOGY – Medtronic Symposium
Next article
SOLACI-CACI 2021 | Leading with Evidence, Choosing With Confidence – MICROPORT Symposium
solaci
solaci

More articles by this author

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Dr. Juan Manuel Pérez - 0
Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Dr. Andrés Rodríguez - 0
Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Dr. Omar Tupayachi - 0
The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 0
Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Dr. Juan Manuel Pérez - 0
Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Dr. Juan Manuel Pérez - 0
Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...